Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes | Citedby Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes

Mol Cancer Ther (2018) 17 (12): 2575–2585.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers

Hatem Hussein Bayoumi
Mohamed-Kamal Ibrahim
Mohammed A. Dahab
Fathalla Khedr
Khaled El-Adl

RSC Advances (2024) 14 (37): 27110.

Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms

Kristin Holl
Nicolas Chatain
Susanne Krapp
Julian Baumeister
Tiago Maié
Sarah Schmitz
Anja Scheufen
Nathalie Brock
Steffen Koschmieder
Daniel Moreno-Andrés

Scientific Reports (2024) 14 (1)

Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers

Marc Payton
Brian Belmontes
Kelly Hanestad
Jodi Moriguchi
Kui Chen
John D. McCarter
Grace Chung
Maria Stefania Ninniri
Jan Sun
Raffi Manoukian
Stuart Chambers
Seok-Man Ho
Robert J. M. Kurzeja
Katheryne Z. Edson
Upendra P. Dahal
Tian Wu
Sharon Wannberg
Pedro J. Beltran
Jude Canon
Andrew S. Boghossian
Matthew G. Rees
Melissa M. Ronan
Jennifer A. Roth
Sheroy Minocherhomji
Matthew P. Bourbeau
Jennifer R. Allen
Angela Coxon
Nuria A. Tamayo
Paul E. Hughes

Nature Cancer (2023) 5 (1): 66.

Editorial: Genetics and Molecular Mechanisms of Oral and Esophageal Squamous Cell Carcinoma

Bin Qiao
Shuaize Li
Die Wang
Di Wu

Frontiers in Oncology (2022) 12

Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy

Weiguo Zhang
Guopan Yu
Hongying Zhang
Mahesh Basyal
Charlie Ly
Bin Yuan
Vivian Ruvolo
Sujan Piya
Seemana Bhattacharya
Qi Zhang
Gautam Borthakur
Venkata Battula
Marina Konopleva
William G. Rice
Michael Andreeff

Haematologica (2022) 108 (6): 1500.

AMG900 as novel inhibitor of the translationally controlled tumor protein

Nicolas Fischer
Ean-Jeong Seo
Anette Klinger
Edmond Fleischer
Thomas Efferth

Chemico-Biological Interactions (2021) 334: 109349.

Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations

Fathalla Khedr
Mohamed‐Kamal Ibrahim
Ibrahim H. Eissa
Hamada S. Abulkhair
Khaled El‐Adl

Archiv der Pharmazie (2021) 354 (11)

Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer

Naheed Arfin Borah
Mamatha M. Reddy

Molecules (2021) 26 (7): 1981.

Stress-Induced Polyploid Giant Cancer Cells: Unique Way of Formation and Non-Negligible Characteristics

Yanwei Song
Yucui Zhao
Zheng Deng
Ruyi Zhao
Qian Huang

Frontiers in Oncology (2021) 11

Chromosomal Instability in Acute Myeloid Leukemia

Mateus de Oliveira Lisboa
Paulo Roberto Slud Brofman
Ana Teresa Schmid-Braz
Aline Rangel-Pozzo
Sabine Mai

Cancers (2021) 13 (11): 2655.

Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine

Linah A. Shahoumi
W. Andrew Yeudall

EPMA Journal (2019) 10 (3): 291.

The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?

Andrea Ghelli Luserna di Rorà
Giovanni Martinelli
Giorgia Simonetti

Journal of Hematology & Oncology (2019) 12 (1)